Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2025-12-24 @ 12:50 PM
NCT ID:
NCT06278961
Eligibility Criteria:
Inclusion Criteria:
* Infants born full-term with typical development, bithweight \>2500g
* Infants with a history of brochopulmonary dysplasia, defined as having a preterm birth (\<33 weeks gestational age) and requiring supplemental oxygen beyond 36 weeks gestational age
* Infants with neonatal encephalopathy, who required hypothermic cooling treatment
* Infants born \<36 weeks gestational age
* Infants born in a multiple gestation pregnancy
* Infants with a diagnosis of Trisomy 21
* Infants born and diagnosed with SMA prenatally, via newborn screening assessment or prior to 10 weeks corrected age
* Infants are less than 10 weeks corrected age at time of enrollment
Exclusion Criteria:
* Children who are enrolled in DCFS custody
* Parent or infant guardian does not have a smartphone
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
10 Weeks
Maximum Age:
20 Weeks
Study:
NCT06278961
Study Brief:
Protocol Section:
NCT06278961